These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7858025)

  • 1. In situ analysis of cellular proliferation in canine, feline and equine tumors by immunohistochemistry: a comparison of bromodeoxyuridine, proliferating cell nuclear antigen, and interchromatin-associated antigen immunostaining techniques.
    Théon AP; Metzger L; Griffey S
    J Vet Diagn Invest; 1994 Oct; 6(4):453-7. PubMed ID: 7858025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
    Zacchetti A; van Garderen E; Teske E; Nederbragt H; Dierendonck JH; Rutteman GR
    APMIS; 2003 Mar; 111(3):430-8. PubMed ID: 12752223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of hepatocytic proliferation in the laboratory mouse. A comparative study using immunohistochemical detection of bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression.
    Lardelli P; Perentes E; Meier G; Navarro N; Ettlin RA
    Exp Toxicol Pathol; 1994 Jul; 46(2):95-100. PubMed ID: 7987078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
    Lee KS; Yang WI
    Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours.
    Preziosi R; Sarli G; Benazzi C; Marcato PS
    J Comp Pathol; 1995 Nov; 113(4):301-13. PubMed ID: 8746954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
    Kang SM; Kim WH; Kim CW; Kim YI
    J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
    Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
    Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tumor cell proliferation and sex-hormone receptors on effectiveness of radiation therapy for dogs with incompletely resected meningiomas.
    Théon AP; Lecouteur RA; Carr EA; Griffey SM
    J Am Vet Med Assoc; 2000 Mar; 216(5):701-7, 684-5. PubMed ID: 10707685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2'-deoxyuridine.
    Connolly KM; Bogdanffy MS
    J Histochem Cytochem; 1993 Jan; 41(1):1-6. PubMed ID: 7678022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic and immunohistochemical studies of granular cell tumors in seven dogs, three cats, one horse, and one bird.
    Patnaik AK
    Vet Pathol; 1993 Mar; 30(2):176-85. PubMed ID: 8470338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
    Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
    J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
    Eldrige SR; Butterworth BE; Goldsworthy TL
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
    Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
    J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of proliferative activity by anti-PCNA monoclonal antibodies in formalin-fixed, paraffin-embedded samples and correlation with mitotic index.
    Sarli G; Benazzi C; Preziosi R; Marcato PS
    Vet Pathol; 1995 Jan; 32(1):93-6. PubMed ID: 7725609
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
    Tinnemans MM; Lenders MH; ten Velde GP; Wagenaar SS; Blijham GH; Ramaekers FC; Schutte B
    Virchows Arch; 1995; 427(3):295-301. PubMed ID: 7496600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.
    Weaver JR; Gan Y; Au JL
    Pharm Res; 1998 Oct; 15(10):1546-51. PubMed ID: 9794496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.